HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DiSaia, P. J. Search for Related Content PubMed PubMed Citation Articles by DiSaia, P. J.

CA: A Cancer Journal for Clinicians, Vol 39, 135-154, Copyright © 1989 by American Cancer Society

Conservative Management Of the Patient with Early Gynecologic Cancer

¹ The Dorothy Marsh Chair in Reproductive Biology and Professor in the Department of Obstetrics and Gynecology at California College of Medicine, University of California Irvine Medical Center, in Orange, California.

Because of the advances in the methodology of staging and a better understanding of the natural history of most gynecologic cancers, it seems appropriate to begin tailoring therapy to the extent of disease. This is especially relevant for early invasive cancers of the ovary, cervix, vagina, and vulva, where preservation of childbearing ability and/or sexual function may be possible. The management of every patient with early gynecologic cancer should be individualized, and the risks of conservative therapy should be balanced against the dangers and advantages of more radical therapy. Progress in the management of these diseases now permits "quality of life" to be brought into serious consideration in the treatment of patients with early invasive gynecologic cancers.

This article has been cited by other articles:

				O. Marpeau, J. Schilder, Y. Zafrani, C. Uzan, S. Gouy, C. Lhomme, and P. Morice Prognosis of Patients Who Relapse after Fertility-Sparing Surgery in Epithelial Ovarian Cancer Ann. Surg. Oncol., February 1, 2008; 15(2): 478 - 483. [Abstract] [Full Text] [PDF]

				P. Morice, E. Leblanc, A. Rey, M. Baron, D. Querleu, J. Blanchot, P. Duvillard, C. Lhomme, D. Castaigne, J. M. Classe, et al. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Societe Francaise d'Oncologie Gynecologique) Hum. Reprod., May 1, 2005; 20(5): 1379 - 1385. [Abstract] [Full Text] [PDF]